Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
da Silva KN, Gobatto ALN, Costa-Ferro ZSM, Cavalcante BRR, Caria ACI, de Aragão França LS, Nonaka CKV, de Macêdo Lima F, Lopes-Pacheco M, Rocco PRM, de Freitas Souza BS.
da Silva KN, et al.
Stem Cell Res Ther. 2021 Jul 27;12(1):425. doi: 10.1186/s13287-021-02502-7.
Stem Cell Res Ther. 2021.
PMID: 34315546
Free PMC article.
Review.
Finally, we present a critical analysis of the risks, limitations, challenges, and opportunities that place MSC-based products as a therapeutic strategy that may complement the current arsenal against COVID-19 and reduce the pandemic's unmet medical needs....
Finally, we present a critical analysis of the risks, limitations, challenges, and opportunities that place MSC-based products as a therapeu …